Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. The rate of progression was 57% lower in the group receiving anal HSIL treatment as compared to the group ...
Originally published by Harvard Health. What Is It? Anal cancer is an uncontrolled growth of abnormal cells in the anus. ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.